TFF Pharmaceuticals, Inc.

NasdaqCM:TFFP Stock Report

Market Cap: US$6.5m

TFF Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:TFFP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 23SellUS$94,433Carlson Capital, L.P.Company8,640US$10.94
15 Aug 23BuyUS$30,000Zamaneh MikhakIndividual4,800US$6.25
15 Aug 23BuyUS$5,000Kirk ColemanIndividual800US$6.25
15 Aug 23BuyUS$10,000Robert MillsIndividual1,600US$6.25
15 Aug 23BuyUS$5,000Brandi RobertsIndividual800US$6.25
15 Aug 23BuyUS$5,000Stephen RocamboliIndividual800US$6.25
15 Aug 23BuyUS$150,000Harlan WeismanIndividual24,000US$6.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TFFP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,3720.0545%
Public Companies30,9201.23%
Individual Insiders61,5302.44%
Hedge Funds193,9607.7%
Institutions211,2728.39%
General Public2,020,16680.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 74%.

Top Shareholders

Top 25 shareholders own 19.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.7%
Carlson Capital, L.P.
193,960US$500.4k-0.53%0.05%
1.59%
DRW Trading Group, Asset Management Arm
40,000US$103.2k0%no data
1.56%
Westside Investment Management, LLC
39,225US$101.2k382%0.03%
1.34%
The Vanguard Group, Inc.
33,873US$87.4k-0.01%no data
1.29%
Harlan Weisman
32,585US$84.1k0%no data
1.23%
Aileron Therapeutics, Inc.
30,920US$79.8k0%no data
1.17%
Aigh Capital Management, LLC
29,482US$76.1k-72.2%0.04%
1.03%
Bios Equity Partners LP
26,064US$67.2k0%no data
0.62%
Geode Capital Management, LLC
15,720US$40.6k55%no data
0.47%
Laurence Lytton
11,900US$30.7k-90.5%no data
0.46%
Renaissance Technologies LLC
11,497US$29.7k84.8%no data
0.34%
BlackRock, Inc.
8,527US$22.0k0.05%no data
0.23%
Aaron Glenn Fletcher
5,739US$14.8k0%no data
0.21%
Zamaneh Mikhak
5,400US$13.9k0%no data
0.089%
Robert Mills
2,239US$5.8k0%no data
0.072%
UBS Asset Management AG
1,813US$4.7k-50.6%no data
0.057%
Stephen Rocamboli
1,440US$3.7k0%no data
0.057%
Kirk Coleman
1,427US$3.7k0%no data
0.054%
Tower Research Capital LLC
1,372US$3.5k147%no data
0.054%
Newbridge Financial Services Group, Inc.
1,352US$3.5k441%no data
0.042%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,070US$2.8k53,400%no data
0.035%
The University of Texas/Texas A&M Investment Management Company
882US$2.3k0%no data
0.032%
Brandi Roberts
800US$2.1k0%no data
0.029%
ORG Partners LLC
740US$1.9k0%no data
0.013%
Venturi Wealth Management, LLC
330US$851.40%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.